Self-reported adverse events associated with 8-Tetrahydrocannabinol (Delta-8-THC) Use
[ 2 ] In this article, we review the history of Epitalon, discuss what researchers currently understand about how it may work, and highlight the limitations of existing research
Several factors contribute to it: High research and development costs: These medications required years of research, clinical trials, and safety testing, which collectively cost manufacturers billions of dollars before they were approved
References Isaeva, M
Joshua Poole Industry news Industry news Category news Category news Reports Key trends Multimedia Journal Events Suppliers Home Industry news Industry news Category news Category news Reports Key trends Multimedia Events Suppliers IFT FIRST 2026 review: GLP-1 ripple effect reshapes functional food innovation Joshua Poole Key takeaways GLP-1 use accelerates wider demand for satiety, nutrient density, sustained energy, and digestive support
Retatrutide is not yet approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and is currently being evaluated in clinical trials
